In IBD, flow cytometric analyses of myeloid cells from both CD and UC colon tissue identified CD64+ myeloid cells as a primary source of IL-23 in inflamed tissue (29, 30). The gene discussed is FCGR1A; the disease is inflammatory bowel disease.